These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 19188169

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary?
    Geurts TW, Nederlof PM, van den Brekel MW, van't Veer LJ, de Jong D, Hart AA, van Zandwijk N, Klomp H, Balm AJ, van Velthuysen ML.
    Clin Cancer Res; 2005 Sep 15; 11(18):6608-14. PubMed ID: 16166439
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.
    González MV, Pello MF, López-Larrea C, Suárez C, Menéndez MJ, Coto E.
    Clin Cancer Res; 1995 Sep 15; 1(9):1043-9. PubMed ID: 9816078
    [Abstract] [Full Text] [Related]

  • 6. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.
    van Houten VM, Leemans CR, Kummer JA, Dijkstra J, Kuik DJ, van den Brekel MW, Snow GB, Brakenhoff RH.
    Clin Cancer Res; 2004 Jun 01; 10(11):3614-20. PubMed ID: 15173067
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study.
    Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, Kummer JA, Leemans CR, Braakhuis BJ.
    Clin Cancer Res; 2004 Jun 01; 10(11):3607-13. PubMed ID: 15173066
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
    Libè R, Groussin L, Tissier F, Elie C, René-Corail F, Fratticci A, Jullian E, Beck-Peccoz P, Bertagna X, Gicquel C, Bertherat J.
    Clin Cancer Res; 2007 Feb 01; 13(3):844-50. PubMed ID: 17289876
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative mutational profiling in the assessment of lung lesions: should it be the standard of care?
    Moffatt-Bruce SD, Ross P, Leon ME, He G, Finkelstein SD, Vaida AM, Iwenofu OH, Frankel WL, Hitchcock CL.
    Ann Thorac Surg; 2010 Aug 01; 90(2):388-96. PubMed ID: 20667316
    [Abstract] [Full Text] [Related]

  • 17. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
    van Houten VM, Tabor MP, van den Brekel MW, Kummer JA, Denkers F, Dijkstra J, Leemans R, van der Waal I, Snow GB, Brakenhoff RH.
    J Pathol; 2002 Dec 01; 198(4):476-86. PubMed ID: 12434417
    [Abstract] [Full Text] [Related]

  • 18. Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer.
    Marsit CJ, Hasegawa M, Hirao T, Kim DH, Aldape K, Hinds PW, Wiencke JK, Nelson HH, Kelsey KT.
    Cancer Res; 2004 Dec 01; 64(23):8702-7. PubMed ID: 15574780
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.